Conference Paper
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome
Fecha
2016Registro en:
16, 1-2, 62-68
16602854
Autor
Tramutola A.
Lanzillotta C.
Arena A.
Barone E.
Perluigi M.
Di Domenico F.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
Di Domenico F.; Tramutola A.; Barone E.; Lanzillotta C.; Defever O.; Arena A.; Zuliani I.; Foppoli C.; Iavarone F.; Vincenzoni F.; Castagnola M.; Butterfield D.A.; Perluigi M. (Elsevier B.V., 2019) -
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Tramutola A.; Lanzillotta C.; Barone E.; Arena A.; Zuliani I.; Mosca L.; Blarzino C.; Butterfield D.A.; Perluigi M.; Di Domenico F. (BioMed Central Ltd., 2018) -
A Central Role For Neuronal Amp-activated Protein Kinase (ampk) And Mammalian Target Of Rapamycin (mtor) In High-protein Diet-induced Weight Loss.
Ropelle, Eduardo R; Pauli, José R; Fernandes, Maria Fernanda A; Rocco, Silvana A; Marin, Rodrigo M; Morari, Joseane; Souza, Kellen K; Dias, Marília M; Gomes-Marcondes, Maria C; Gontijo, José A R; Franchini, Kleber G; Velloso, Lício A; Saad, Mario J A; Carvalheira, José B C